{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:35:15Z","timestamp":1784010915876,"version":"3.55.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Loratadine and montelukast are clinical first-line drugs in the treatment of allergic rhinitis (AR). However, there is no clear evidence of the efficacy of loratadine combined with montelukast in the treatment of AR. This study aimed to evaluate the efficacy and safety of the loratadine-montelukast combination on AR.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this meta-analysis, searches were conducted on PubMed, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, and China National Knowledge Infrastructure (CNKI). The search terms included loratadine, montelukast, allergic rhinitis, and clinical trials. Meta-analyses were conducted using Rev Man 5.3 and Stata 15 statistical software.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 23 studies with 4,902 participants were enrolled. For the primary outcome, pooled results showed that loratadine-montelukast can significantly reduce total nasal symptom scores (TNSS), when compared with loratadine (SMD, \u22121.00; 95% CI, \u22121.35 to \u22120.65, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001), montelukast (SMD, \u22120.46; 95% CI, \u22120.68 to \u22120.25, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001), or placebo (SMD, \u22120.93; 95% CI, \u22121.37 to \u22120.49, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001). For secondary outcomes, pooled results showed that compared with loratadine, loratadine-montelukast can significantly improve nasal congestion, nasal itching, nasal sneezing, nasal rhinorrhea, and rhinoconjunctivitis quality of life questionnaires (RQLQ). Compared with montelukast, loratadine-montelukast can significantly improve nasal itching, and nasal sneezing. Compared with placebo, loratadine-montelukast can significantly improve nasal congestion, and RQLQ.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Loratadine-montelukast combination is superior to loratadine monotherapy, montelukast monotherapy, or placebo in improving AR symptoms. Therefore, loratadine-montelukast combination can be an option for patients with moderate-severe AR or poorly response to monotherapy.<\/jats:p><jats:p>Systematic review registration number: <jats:ext-link>clinicaltrials.gov<\/jats:ext-link>, identifier CRD42023397519.<\/jats:p>","DOI":"10.3389\/fphar.2023.1287320","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T06:22:22Z","timestamp":1697523742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis"],"prefix":"10.3389","volume":"14","author":[{"given":"Huan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5005\/ijcdas-58-2-103","article-title":"\"Comparison of effect of levocetirizine or montelukast alone and in combination on symptoms of allergic rhinitis.\"","volume":"58","author":"Andhale","year":"2016","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bjorl.2016.05.008","article-title":"\"Rhinitis as an associated factor for anxiety and depression amongst adults.\"","volume":"83","author":"Bedolla-Barajas","year":"2017","journal-title":"Braz J. Otorhinolaryngol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.iac.2015.12.004","article-title":"\"Allergic rhinitis: mechanisms and treatment.\"","volume":"36","author":"Bernstein","year":"2016","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"B4","first-page":"63","article-title":"\"Clinical effect analysis of montelukast combined with loratadine in the treatment of allergic rhinitis.\"","volume":"30","author":"Bian","year":"2018","journal-title":"Med. J. Chin. People\u2019s Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13223-018-0314-1","article-title":"\"The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.\"","volume":"15","author":"Bjermer","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","article-title":"\"Allergic rhinitis.\"","volume":"6","author":"Bousquet","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.4049\/jimmunol.151.7.3853","article-title":"\"Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.\"","volume":"151","author":"Bradding","year":"1993","journal-title":"J. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.16542\/j.cnki.issn.1007-4856.2017.03.010","article-title":"\"Effects of loratadine combined with montelukast tablet on relieving nasal congestion in children with allergic rhinitis.\"","volume":"25","author":"Cai","year":"2017","journal-title":"Chin. J. Otorhinolaryngol. Integ Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4168\/aair.2018.10.4.300","article-title":"\"Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis.\"","volume":"10","author":"Cheng","year":"2018","journal-title":"Allergy Asthma Immunol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11882-013-0341-4","article-title":"\"Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.\"","volume":"13","author":"Cobano\u011flu","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2500\/aap.2009.30.3234","article-title":"\"Onset of action of loratadine\/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.\"","volume":"30","author":"Day","year":"2009","journal-title":"Allergy Asthma Proc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s1081-1206(10)63284-x","article-title":"\"Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.\"","volume":"82","author":"Dockhorn","year":"1999","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B13","first-page":"72","article-title":"\"Efficacy observation of montelukast combined with loratadine in the treatment of allergic rhinitis.\"","volume":"14","author":"Gong","year":"2016","journal-title":"J. China Prescr. Drug"},{"key":"B14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2500\/ajra.2016.30.4391","article-title":"\"Combination therapy in allergic rhinitis: what works and what does not work.\"","volume":"30","author":"Greiwe","year":"2016","journal-title":"Am. J. Rhinol. Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2165\/00003495-199448040-00009","article-title":"\"Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.\"","volume":"48","author":"Haria","year":"1994","journal-title":"Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"\"Measuring inconsistency in meta-analyses.\"","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"B17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1398-9995.1995.tb05075.x","article-title":"\"Nasal histamine challenge in nonallergic and allergic subjects evaluated by acoustic rhinometry.\"","volume":"50","author":"Hilberg","year":"1995","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-0031-1296281","article-title":"\"Onset of action of loratadine\/montelukast in seasonal allergic rhinitis patients exposed to grass pollen.\"","volume":"60","author":"Horak","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"B19","first-page":"135","article-title":"\"Efficacy observation of montelukast combined with loratadine in the treatment of allergic rhinitis in children.\"","volume":"15","author":"Huang","year":"2009","journal-title":"Contemp. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1442-200X.2007.02375.x","article-title":"\"Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.\"","volume":"49","author":"Hung","year":"2007","journal-title":"Pediatr. Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.clinthera.2018.04.021","article-title":"\"A randomized, multicenter, double-blind, phase III study to evaluate the efficacy on allergic rhinitis and safety of a combination therapy of montelukast and levocetirizine in patients with asthma and allergic rhinitis.\"","volume":"40","author":"Kim","year":"2018","journal-title":"Clin. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s1081-1206(10)61468-8","article-title":"\"Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.\"","volume":"93","author":"LaForce","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B23","first-page":"25","article-title":"\"Clinical observation of efficacy of montelukast combined with Loratadine in treatment of allergic rhinitis.\"","volume":"31","author":"Li","year":"2019","journal-title":"Med. J. Chin. People's Health"},{"key":"B24","first-page":"74","article-title":"\"Clinical efficacy of montelukast combined with loratadine in the treatment of allergic rhinitis.\"","volume":"12","author":"Lin","year":"2017","journal-title":"CHINA J. Pharm. Econ."},{"key":"B25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0140-6736(98)09019-9","article-title":"\"Leukotriene-receptor antagonists.\"","volume":"353","author":"Lipworth","year":"1999","journal-title":"Lancet"},{"key":"B26","first-page":"280","article-title":"\"Effect of loratadine combined with montelukast sodium on serum ICAM-1 ECP EOS and CSF in patients with allergic rhinitis.\"","volume":"25","author":"Liu","year":"2019","journal-title":"HEBEI Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3109\/02770900903104540","article-title":"\"Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.\"","volume":"46","author":"Lu","year":"2009","journal-title":"J. Asthma"},{"key":"B28","first-page":"115","article-title":"\"Effect of montelukast sodium chewable tablets and loratadine tablets combined with triamcinolone acetonide nasal spray in the treatment of allergic rhinitis in children.\"","volume":"29","author":"Lu","year":"2022","journal-title":"CHINA Mod. Med."},{"key":"B29","first-page":"6","article-title":"\"Impact of climate changes on allergic diseases.\"","volume":"76","author":"Maladkar","year":"2023","journal-title":"Indian Pract."},{"key":"B30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1067\/mai.2000.106040","article-title":"\"Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.\"","volume":"105","author":"Meltzer","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"B31","first-page":"111","article-title":"\"Effect analysis of montelukast combined with loratadine tablets in the treatment of allergic rhinitis.\"","volume":"10","author":"Miao","year":"2020","journal-title":"Front. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"\"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.\"","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1056\/nejm199109193251206","article-title":"\"Allergic rhinitis.\"","volume":"325","author":"Naclerio","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2500\/aap.2007.28.2934","article-title":"\"The burden of allergic rhinitis.\"","volume":"28","author":"Nathan","year":"2007","journal-title":"Allergy Asthma Proc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/s1081-1206(10)61891-1","article-title":"\"Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.\"","volume":"88","author":"Nayak","year":"2002","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5415\/apallergy.2011.1.3.157","article-title":"\"Overview on the pathomechanisms of allergic rhinitis.\"","volume":"1","author":"Pawankar","year":"2011","journal-title":"Asia Pac. Allergy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S248","DOI":"10.1016\/s0091-6749(96)70073-8","article-title":"\"Heterogeneity of mast cells and T cells in the nasal mucosa.\"","volume":"98","author":"Pawankar","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1164\/ajrccm.152.6.8520776","article-title":"\"Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis.\"","volume":"152","author":"Pawankar","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2222.2006.02498.x","article-title":"\"Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.\"","volume":"36","author":"Peters-Golden","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1046\/j.1365-2222.2002.01422.x","article-title":"\"Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.\"","volume":"32","author":"Philip","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2500\/aap.2009.30.3228","article-title":"\"Efficacy and safety of fixed-dose loratadine\/montelukast in seasonal allergic rhinitis: effects on nasal congestion.\"","volume":"30","author":"Prenner","year":"2009","journal-title":"Allergy Asthma Proc."},{"key":"B42","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1067\/mai.2002.124467","article-title":"\"Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.\"","volume":"109","author":"Pullerits","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"B43","first-page":"9","article-title":"\"Clinical analysis of montelukast combined with loratadine in the treatment of allergic rhinitis.\"","author":"Qiao","year":"2020","journal-title":"Diet Health"},{"key":"B44","first-page":"118","article-title":"\"A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.\"","volume":"47","author":"Ratner","year":"1998","journal-title":"J. Fam. Pract."},{"key":"B45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4193\/Rhin21.087","article-title":"\"Anxiety and depression risk in patients with allergic rhinitis: a systematic review and meta-analysis.\"","volume":"59","author":"Rodrigues","year":"2021","journal-title":"Rhinology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/lary.30318","article-title":"\"Allergic rhinitis seasonality, severity, and disease control influence anxiety and depression.\"","volume":"133","author":"Rodrigues","year":"2022","journal-title":"Laryngoscope"},{"key":"B47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bjorl.2018.09.007","article-title":"\"Individualized treatment for allergic rhinitis based on key nasal clinical manifestations combined with histamine and leukotriene D4 levels.\"","volume":"86","author":"Shen","year":"2020","journal-title":"Braz J. Otorhinolaryngol."},{"key":"B48","first-page":"13","article-title":"\"Clinical effect of montelukast sodium combined with loratadine in the treatment of allergic rhinitis.\"","volume":"6","author":"Shi","year":"2022","journal-title":"Mod. Med. Health Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000441871","article-title":"\"Role of cysteinyl leukotrienes in allergic rhinitis.\"","volume":"77","author":"Shirasaki","year":"2016","journal-title":"Excell. Otolaryngology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1513\/pats.201008-057RN","article-title":"\"Pathophysiology of allergic and nonallergic rhinitis.\"","volume":"8","author":"Sin","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"B51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11882-007-0010-6","article-title":"\"Leukotriene synthesis inhibitors versus antagonists: the pros and cons.\"","volume":"7","author":"Steinke","year":"2007","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.anai.2013.05.020","article-title":"\"Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation.\"","volume":"111","author":"Thompson","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1046\/j.1398-9995.2003.00261.x","article-title":"\"Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.\"","volume":"58","author":"van Adelsberg","year":"2003","journal-title":"Allergy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1034\/j.1398-9995.2001.00775.x","article-title":"\"Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers.\"","volume":"56","author":"Wang","year":"2001","journal-title":"Allergy"},{"key":"B55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2273.1996.tb01085.x","article-title":"\"Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism.\"","volume":"21","author":"Wood-Baker","year":"1996","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"B56","first-page":"110","article-title":"\"Efficacy observation of montelukast combined with loratadine in the treatment of childhood allergic rhinitis.\"","author":"Xiao","year":"2008","journal-title":"CHINA Mod. Dr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.2500\/aap.2012.33.3514","article-title":"\"Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.\"","volume":"33","author":"Yamamoto","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"B58","first-page":"49","article-title":"\"Efficacy analysis of montelukast and loratadine in the treatment of allergic rhinitis.\"","author":"Zhang","year":"2021","journal-title":"Health Guide"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1287320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T06:22:38Z","timestamp":1697523758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1287320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":58,"alternative-id":["10.3389\/fphar.2023.1287320"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1287320","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"article-number":"1287320"}}